Other languages Themis Medicare Limited NSE India S.E.

Equities

THEMISMED

INE083B01024

Market Closed - NSE India S.E. Other stock markets 05:13:56 28/06/2024 pm IST			5-day change	1st Jan Change
209.7 ^INR	-0.03%		-4.53%	-1.88%

14/05	Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
14/05	Themis Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or after July 22, 2024	14/05
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	14/05
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	14/05
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	10/02
Themis Medicare Limited Launches REMITHEM	10/11
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04/11
Themis Medicare Limited Announces Incorporation of Wholly Owned Subsidiary	20/23/20
Themis Medicare Limited Announces Cessation of Vijay Agarwal as Independent Director	09/23/09
Themis Medicare Limited Appoints Reena Patel as Alternate Non-Executive Non- Non-Independent Director to Dr. Adam Demeter, Effective September 11, 2023	07/23/07
Themis Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/23/10
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	13/23/13
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	13/23/13
Themis Medicare Limited Recommends Dividend for Financial Year Ended 31 March 2023	13/23/13
Themis Medicare Limited Announces Board Resignations	02/23/02
Themis Medicare Announces DCGI Approval of Remifentanil Hydrochloride 1mg/2mg for Injection for Import and Marketing	17/23/17
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03/23/03
Themis Medicare Ltd. Launches Lenzetto Â¡Global Brand of Estradiol Novel Drug Delivery System	03/23/03
Themis Medicare Posts Decline in Fiscal Q2 Consolidated Profit	09/22/09
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	07/22/07
NFL Biosciences Partners with Themis Medicare for the Development of NFL-101 in India	05/22/05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Themis Medicare Limited NSE India S.E.

Equities

THEMISMED

INE083B01024

Other languages

Filters